LONDON--(BUSINESS WIRE)-- NextPharma Technologies Holding Limited, a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, today announced the appointment of two new Site Managers and a group VP Quality and Regulatory.
Eric Bertrand assumes full leadership responsibility for the NextPharma Centre of Excellence for Liquids in Limay, France. Eric’s experience in site management stretches over 17 years including FDA site management for B. Braun. Eric has an impressive record in maximising site potential and contributing to strong growth.
Ralf Blesel also assumes full leadership responsibility at the NextPharma Centre of Excellence for Penicillins in Berlin, Germany. Ralf has over thirty years’ experience in the pharmaceutical industry including nine years with Bayer and senior roles within contract manufacturing.
In addition, Nigel Cryer will be joining NextPharma as VP Quality and Regulatory from April 1st 2014, assuming functional leadership for the NextPharma Quality function. Nigel has extensive international experience leading quality teams and successfully completing inspections with the FDA and other regulatory agencies.
“I am extremely pleased to be formally welcoming Eric, Ralf and Nigel to the NextPharma team Andrew Kelley, NextPharma’s Chief Operating Officer, commented. I know that each of them will bring a remarkable wealth of industry and leadership experience to their respective roles.”
Franck Latrille, NextPharma’s Chief Executive Officer, also stated: “I am confident that NextPharma and its customers will significantly benefit from the proven expertise of Eric, Ralf and Nigel and that they will contribute significantly to the implementation of NextPharma’s strategy.”
Notes to Editors:
NextPharma, headquartered in the UK and founded in 2000, is a world class outsourcing partner to the pharmaceutical and biotechnology industry. The company:
NextPharma Technologies Holding Limited (www.nextpharma.com)
Executive Vice President Corporate Development
Tel: +44 (0) 1483 479 120
Source: NextPharma Technologies